SciDev Ltd (SDV) AI Stock Analysis

• Market Cap: AU$64.63M
• Dividend Yield: N/A
• Average Volume (3M): 156.16K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.08
• Revenue Growth: -5.37%
• EPS Growth: -140.00%
• Country: AU
• Employees: 22
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): >-0.01
• Shares Outstanding: 190,088,580
• 10 Day Avg. Volume: 144,930
• 30 Day Avg. Volume: 156,164
• PEG Ratio: 0.51
• Price to Book (P/B): 1.26
• Price to Sales (P/S): 0.61
• P/FCF Ratio: 80.53
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$0.60
• Price Target Upside: 62.16% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 51 Neutral
• Price Target: AU$0.50 ▲(35.14% Upside)

SciDev Ltd's overall stock score is primarily influenced by its mixed financial performance, with stable cost management and leverage but challenges in profitability and cash flow. Technical analysis shows positive momentum, providing some support to the stock. However, the valuation is concerning due to a negative P/E ratio and lack of dividend yield, indicating potential overvaluation. The absence of earnings call data and corporate events means these factors do not influence the score.

SciDev Ltd Business Overview & Revenue Model

Company Description

SciDev Ltd (SDV) is an innovative company focused on providing advanced scientific solutions and technologies across various sectors, including pharmaceuticals, biotechnology, and environmental science. The company specializes in the development and commercialization of cutting-edge tools and services that enhance research and development processes, aiming to accelerate scientific discovery and improve outcomes in health and sustainability.

How the Company Makes Money

SciDev Ltd generates revenue primarily through the sale of its proprietary scientific instruments and software solutions, which are utilized by research institutions and commercial laboratories. Additionally, the company earns income from providing consultancy services, training programs, and technical support related to its products. Key revenue streams include direct product sales, subscription fees for software services, and project-based contracts with academic and industry partners. Strategic partnerships with leading research organizations and collaborations with other technology firms further bolster its earnings by expanding its market reach and enhancing product offerings.

SciDev Ltd Financial Statement Overview

Summary

SciDev Ltd faces challenges in achieving consistent revenue growth and profitability, as evidenced by negative net profit margins and declining free cash flow. The balance sheet remains stable with low leverage, but the company struggles to generate returns on equity. Overall, the financial health is mixed, with strengths in cost management and leverage offset by weaknesses in profitability and cash flow generation.

Income Statement

SciDev Ltd has shown fluctuating revenue growth with a recent decline of 4.96%. The gross profit margin is relatively stable at 32.26%, indicating efficient cost management. However, the net profit margin is negative at -0.85%, reflecting challenges in achieving profitability. EBIT and EBITDA margins are modest, suggesting limited operational efficiency improvements.

Balance Sheet

The company maintains a low debt-to-equity ratio of 0.13, indicating conservative leverage. However, the return on equity is negative at -1.75%, highlighting challenges in generating returns for shareholders. The equity ratio is not explicitly provided, but the low debt levels suggest a stable financial structure.

Cash Flow

Free cash flow growth has significantly declined by 88.63%, indicating potential liquidity issues. The operating cash flow to net income ratio is low at 0.13, suggesting limited cash generation relative to earnings. The free cash flow to net income ratio is 0.27, reflecting challenges in converting earnings into cash flow.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	103.50M	103.50M	109.09M	89.72M	55.60M	42.52M
Gross Profit	33.39M	33.39M	33.97M	6.83M	3.69M	1.37M
EBITDA	5.91M	5.91M	7.65M	3.92M	1.13M	1.88M
Net Income	-878.00K	-878.00K	2.17M	-339.00K	-616.00K	3.45M
Balance Sheet
Total Assets	75.23M	75.23M	72.01M	67.37M	71.16M	56.15M
Cash, Cash Equivalents and Short-Term Investments	9.68M	9.68M	9.43M	7.73M	14.06M	7.01M
Total Debt	6.26M	6.26M	5.13M	3.48M	2.90M	5.13M
Total Liabilities	25.18M	25.18M	21.78M	19.35M	22.32M	24.54M
Stockholders Equity	50.05M	50.05M	50.24M	48.02M	48.84M	31.61M
Cash Flow
Free Cash Flow	785.00K	785.00K	4.48M	522.00K	-3.83M	-1.92M
Operating Cash Flow	2.87M	2.87M	6.48M	4.81M	-1.31M	-1.32M
Investing Cash Flow	-2.35M	-2.35M	-3.71M	-8.39M	-6.65M	-2.49M
Financing Cash Flow	-390.00K	-390.00K	-1.06M	-2.83M	14.99M	6.34M

SciDev Ltd Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.37
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SDV, the sentiment is Positive. The current price of 0.37 is above the 20-day moving average (MA) of 0.31, above the 50-day MA of 0.32, and above the 200-day MA of 0.37, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 62.72 is Neutral, neither overbought nor oversold. The STOCH value of 38.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:SDV.

SciDev Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
CG1	55 Neutral	AU$41.39M	-5.36	-67.76%	―	7.08%	33.70%
SDV	51 Neutral	AU$64.63M	-73.91	-1.75%	―	-5.37%	-140.00%
SPN	46 Neutral	AU$17.02M	-6.28	-63.81%	―	―	52.66%
CXL	45 Neutral	AU$86.02M	-4.07	-22.28%	―	16.47%	29.53%
AJX	37 Underperform	€11.26M	-2.63	-263.52%	―	-32.85%	28.30%
DTZ	28 Underperform	€33.19M	-3.52	-869.14%	―	340.27%	19.44%

SciDev Ltd Corporate Events

SciDev Secures $19.5 Million Contract for Rum Jungle Rehabilitation

SciDev Ltd has secured a $19.5 million contract for the design and construction of a groundwater treatment plant as part of the Rum Jungle Rehabilitation Project in Australia. This project, a significant environmental remediation effort, aims to treat contaminated groundwater from legacy uranium mining, benefiting the local community and environment. The contract underscores SciDev’s capability in delivering specialized water treatment solutions and enhances its position in the market for large-scale mine rehabilitation.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd Appoints Todd Scott as New CFO

SciDev Ltd has announced the appointment of Todd Scott as the new Chief Financial Officer, effective immediately. With over 20 years of experience in finance and strategic execution across various sectors, Scott is expected to enhance SciDev’s leadership and support its growth strategy. The outgoing CFO, Anna Hooper, is recognized for her significant contributions to the company’s growth and financial management over the past four years.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd Announces New Securities Quotation on ASX

SciDev Ltd has announced a new issuance of 49,556 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX) under the code SDV, effective from October 21, 2025. This move is part of the company’s ongoing efforts to enhance its market presence and provide more liquidity for its stakeholders, reflecting a strategic initiative to bolster its financial standing and operational capabilities.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd Announces 2025 AGM with Key Resolutions on Agenda

SciDev Ltd has announced its 2025 Annual General Meeting (AGM) scheduled for November 20, 2025, in Sydney. The meeting will address several key resolutions, including the adoption of the Remuneration Report, the election and re-election of directors, and the approval of an additional 10% placement capacity. These resolutions are significant for SciDev’s governance and strategic direction, potentially impacting shareholder value and the company’s market positioning.

The most recent analyst rating on (AU:SDV) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd Announces 2025 AGM and Director Nominations

SciDev Ltd has announced that its 2025 Annual General Meeting (AGM) will be held on November 20, 2025, where the re-election of Directors will be considered. The deadline for director nominations is October 2, 2025. This announcement reflects SciDev’s ongoing corporate governance practices and may influence its strategic direction and leadership structure, impacting stakeholders and potentially affecting its market positioning.

The most recent analyst rating on (AU:SDV) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd Unveils Growth Blueprint in FY25 Investor Presentation

SciDev Ltd has announced a blueprint for growth as part of its FY25 investor presentation, highlighting its commitment to solving complex water problems through innovative solutions. The company has treated over 8 billion litres of PFAS-contaminated water and serviced 380 wells with its CatChek technology, emphasizing its significant impact on improving operational and environmental outcomes across various heavy industries. This strategic focus is expected to strengthen SciDev’s market position and offer substantial benefits to its stakeholders.

The most recent analyst rating on (AU:SDV) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd Reports FY25 Results with Strategic Growth and Market Expansion

SciDev Ltd reported FY25 revenue of $103.4 million, a slight decrease from the previous year, attributed to a strategic shift away from commodity chemistry sales and delays in domestic water contracts. Despite this, the company achieved a 28% gross margin and positive cash flow, with significant growth in its CatChek™ product sales and PFAS remediation contracts in the US and Europe. SciDev’s strategic investments and market expansion efforts are expected to drive revenue growth in FY26, with an anticipated range of $120–140 million.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd to Announce FY25 Financial Results and Host Investor Webinar

SciDev Ltd is set to release its FY25 financial results on August 27, 2025, before market opening. The company will host an investor webinar on the same day, where the Managing Director & CEO Seán Halpin and CFO Anna Hooper will discuss the FY25 business activities and highlights, followed by a Q&A session. This announcement reflects SciDev’s ongoing commitment to transparency and engagement with its investors, potentially impacting its market positioning and stakeholder relations.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.